Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Continuous Glucose Monitoring in Inpatients

NCT: NCT06329297 · WITHDRAWN

NCT IDNCT06329297
StatusWITHDRAWN
Start Date2025-10
Completion2025-12

Brief Summary

The purpose of this study is to contribute to current research regarding the feasibility and accuracy of CGM in the hospital setting for both the medical and cardiovascular intensive care (ICU) patient populations.

Frequently Asked Questions

What is Continuous Glucose Monitoring in Inpatients?

Continuous Glucose Monitoring in Inpatients is a clinical trial registered under NCT06329297. Current status: WITHDRAWN.

What is the status of NCT06329297?

The current status of NCT06329297 (Continuous Glucose Monitoring in Inpatients) is: WITHDRAWN.

When did Continuous Glucose Monitoring in Inpatients start?

Continuous Glucose Monitoring in Inpatients started on 2025-10.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.